Petition urging NICE to approve Benlysta

Benlysta is the first new drug for Lupus in 52 years and it has already been approved as a treatment for Lupus by the US Food and Drug Administration (FDA).

The United Kingdom's National Institute for Health and Clinical Excellence (NICE) recently released its preliminary recommendation to NOT cover the cost of Benlysta(R) through the National Health Service. As well as denying people with Lupus in the UK the chance to try this new treatment, NICE's preliminary recommendation could have a devastating international impact on the survival of this important new treatment, and it may have a chilling effect on the future development of new Lupus drugs thereby denying physicians and patients appropriate treatment options.

There are many people with Fibro who also have Lupus or who have relatives and friends that do. This is an important drug. One day it could be one of our drugs they are turning down.

Join us in our call to action by urging NICE to recommend that the United Kingdom's National Health Service provide coverage of Benlysta(R) by joining this petition:

www.thepetitionsite.com/1/cover-Benlysta